-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Jade Biosciences, Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
- Jade Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $2,381,000, a 90% increase year-over-year.
- Jade Biosciences, Inc. Net Cash Provided by (Used in) Operating Activities for the twelve months ending 31 Mar 2025 was $49,904,000.
- Jade Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $94,689,000, a 33% decline from 2024.
- Jade Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $71,196,000, a 25% decline from 2023.
- Jade Biosciences, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $56,778,000, a 45% decline from 2022.